Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.

Li-Hua QuQian FangTong YinHui-Mei YiGuang-Bo MeiZi-Zhan HongXue-Bing QiuRui ZhouHui-Fen Dong

Published in: Cancer immunology, immunotherapy : CII (2022)

Overall, our current results indicated that KDM1A/1B/3A/4A/5B/5C and KDM6A could be novel prognostic biomarkers and provide insights into potential immunotherapy targets to HCC patients.